Skip to content
OpenCapital
Get started

LivaNova LIVN Cardiopulmonary — Total Assets

Other segment segments

Neuromodulation
$650.1M+1.3%

Similar metrics at other companies

Boston Scientific logo
BSXCardiovascular — Total assets of reportable segments
$8.25B+11.3%
Cactus logo
WHDPressure Control — Total Assets
$468.06M+6.6%
Cabot Corporation logo
CBTPerformance Chemicals — Total Assets
$1.5B+0.4%
Insight Enterprises logo
NSITAPAC — Total Assets
$472.23M+64.4%
Arcosa logo
ACAConstruction Products — Total Assets
$3.36B+2.1%
Brunswick logo
BCEngine Parts and Accessories — Total Assets
$943.9M+2.4%

Other financials

Income statement

See full
Revenue$362.3M+14.3%
Gross profit$243.7M+12.7%
Operating income$41.5M-14.7%
Net income$22.3M+107%
EPS (diluted)$0.40+107%

Balance sheet

See full
Cash & equivalents$539.7M-26.9%
Total debt$340.9M-49.7%
Total equity$1.2B+17.1%
Total assets$2.5B-1.7%

Cash flow

See full
Operating cash flow$15.2M-36.5%
CapEx$14.3M+32.4%
Free cash flow$926.0K-93.0%

Valuation

See full
Market cap$4.31B+62.8%
Enterprise value$4.11B+58.0%
P/S3×+0.9×

Profitability

See full
Gross margin67.5%-0.5pp
Operating margin13.4%+0.8pp
Net margin-16.1%-18.0pp
FCF margin11.2%-0.2pp

Returns & leverage

See full
Return on equity-17.6%-19.5pp
Debt / equity0.3×-0.4×
Current ratio1.3×-0.2×

Where this comes from

Reported directly by LivaNova in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: LivaNova’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about LivaNova's cardiopulmonary — total assets.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LivaNova's cardiopulmonary — total assets?
LivaNova (LIVN) reported cardiopulmonary — total assets of $1.05B in Q1 2026.
How has LivaNova's cardiopulmonary — total assets changed year-over-year?
LivaNova's cardiopulmonary — total assets increased by 11.3% year-over-year, from $939.84M to $1.05B.
What is the long-term trend for LivaNova's cardiopulmonary — total assets?
Over 3 years (2022 to 2025), LivaNova's cardiopulmonary — total assets has grown at a 5.2% compound annual growth rate (CAGR), from $3.45B to $4.02B.
What does cardiopulmonary — total assets mean?
The total value of resources controlled by the cardiopulmonary segment, including property, plant, equipment, and working capital. This metric is used to evaluate the asset base supporting the segment's operations and its overall capital intensity.